<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer</title>
				<funder ref="#_94jHPGZ">
					<orgName type="full">National Institutes of Health</orgName>
					<orgName type="abbreviated">NIH</orgName>
				</funder>
				<funder ref="#_dt2pg83 #_8pffpmV #_wMkURF3 #_agB9t7j #_69hcWwj #_3Tr8vkb">
					<orgName type="full">unknown</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher>Springer Science and Business Media LLC</publisher>
				<availability status="unknown"><p>Copyright Springer Science and Business Media LLC</p>
				</availability>
				<date type="published" when="2012-03-27">2012 March 27.</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Xifeng</forename><surname>Wu</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution">University of Texas M.D. Anderson Cancer Center</orgName>
								<address>
									<settlement>Houston</settlement>
									<region>Texas</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yuanqing</forename><surname>Ye</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution">University of Texas M.D. Anderson Cancer Center</orgName>
								<address>
									<settlement>Houston</settlement>
									<region>Texas</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lambertus</forename><forename type="middle">A</forename><surname>Kiemeney</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution">Biostatistics &amp; Health Technology Assessment</orgName>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">Radboud University Nijmegen Medical Centre</orgName>
								<address>
									<settlement>Nijmegen</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Department of Urology</orgName>
								<orgName type="institution">Radboud University Nijmegen Medical Centre</orgName>
								<address>
									<settlement>Nijmegen</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="institution">Comprehensive Cancer Center East</orgName>
								<address>
									<settlement>Nijmegen</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Patrick</forename><surname>Sulem</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">deCODE Genetics</orgName>
								<address>
									<settlement>Reykjavik</settlement>
									<country key="IS">Iceland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Thorunn</forename><surname>Rafnar</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">deCODE Genetics</orgName>
								<address>
									<settlement>Reykjavik</settlement>
									<country key="IS">Iceland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Giuseppe</forename><surname>Matullo</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of Genetics, Biology and Biochemistry</orgName>
								<orgName type="institution">University of Torino</orgName>
								<address>
									<settlement>Torino</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="institution">ISI (Institute for Scientific Interchange) Foundation, Villa Gualino</orgName>
								<address>
									<settlement>Torino</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Daniela</forename><surname>Seminara</surname></persName>
							<affiliation key="aff8">
								<orgName type="department" key="dep1">Epidemiology and Genetics Research Program</orgName>
								<orgName type="department" key="dep2">Division of Cancer Control and Population Sciences</orgName>
								<orgName type="institution">National Cancer Institute</orgName>
								<address>
									<settlement>Bethesda</settlement>
									<region>Maryland</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Teruhiko</forename><surname>Yoshida</surname></persName>
							<affiliation key="aff9">
								<orgName type="department">Genetics Division</orgName>
								<orgName type="institution">National Cancer Center Research Institute</orgName>
								<address>
									<settlement>Tokyo</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Norihisa</forename><surname>Saeki</surname></persName>
							<affiliation key="aff9">
								<orgName type="department">Genetics Division</orgName>
								<orgName type="institution">National Cancer Center Research Institute</orgName>
								<address>
									<settlement>Tokyo</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Angeline</forename><forename type="middle">S</forename><surname>Andrew</surname></persName>
							<affiliation key="aff10">
								<orgName type="department" key="dep1">Department of Community and Family Medicine</orgName>
								<orgName type="department" key="dep2">Section of Biostatistics and Epidemiology</orgName>
								<orgName type="department" key="dep3">Dartmouth Medical School</orgName>
								<address>
									<settlement>Hanover</settlement>
									<region>New Hampshire</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Colin</forename><forename type="middle">P</forename><surname>Dinney</surname></persName>
							<affiliation key="aff11">
								<orgName type="department">Department of Urology</orgName>
								<orgName type="institution">University of Texas M.D. Anderson Cancer Center</orgName>
								<address>
									<settlement>Houston</settlement>
									<region>Texas</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bogdan</forename><surname>Czerniak</surname></persName>
							<affiliation key="aff12">
								<orgName type="department">Department of Pathology</orgName>
								<orgName type="institution">University of Texas</orgName>
								<address>
									<addrLine>M.D. Anderson Cancer Center</addrLine>
									<settlement>Houston</settlement>
									<region>Texas</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Zuo-Feng</forename><surname>Zhang</surname></persName>
							<affiliation key="aff13">
								<orgName type="department" key="dep1">Department of Epidemiology</orgName>
								<orgName type="department" key="dep2">School of Public Health</orgName>
								<orgName type="institution">University of California Los Angeles</orgName>
								<address>
									<settlement>Los Angeles</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anne</forename><forename type="middle">E</forename><surname>Kiltie</surname></persName>
							<affiliation key="aff14">
								<orgName type="department">Section of Experimental Oncology</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">D</forename><forename type="middle">Timothy</forename><surname>Bishop</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Paolo</forename><surname>Vineis</surname></persName>
							<affiliation key="aff7">
								<orgName type="institution">ISI (Institute for Scientific Interchange) Foundation, Villa Gualino</orgName>
								<address>
									<settlement>Torino</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
							<affiliation key="aff17">
								<orgName type="department">Department of Epidemiology and Public Health</orgName>
								<orgName type="institution">Imperial College</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stefano</forename><surname>Porru</surname></persName>
							<affiliation key="aff18">
								<orgName type="department">Department of Experimental and Applied Medicine</orgName>
								<orgName type="institution">University of Brescia</orgName>
								<address>
									<settlement>Brescia</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Frank</forename><surname>Buntinx</surname></persName>
							<affiliation key="aff19">
								<orgName type="department">Department of General Practice</orgName>
								<orgName type="institution">Catholic University of Leuven</orgName>
								<address>
									<settlement>Leuven</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
							<affiliation key="aff20">
								<orgName type="department">Department of General Practice</orgName>
								<orgName type="institution">Maastricht University</orgName>
								<address>
									<settlement>Maastricht</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Eliane</forename><surname>Kellen</surname></persName>
							<affiliation key="aff21">
								<orgName type="laboratory">Leuven University Centre for Cancer Prevention</orgName>
								<address>
									<settlement>Leuven</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
							<affiliation key="aff22">
								<orgName type="department">Department of Public Health and Epidemiology</orgName>
								<orgName type="institution">University of Birmingham</orgName>
								<address>
									<settlement>Birmingham</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Maurice</forename><forename type="middle">P</forename><surname>Zeegers</surname></persName>
							<affiliation key="aff22">
								<orgName type="department">Department of Public Health and Epidemiology</orgName>
								<orgName type="institution">University of Birmingham</orgName>
								<address>
									<settlement>Birmingham</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
							<affiliation key="aff23">
								<orgName type="department">Department of Complex Genetics</orgName>
							</affiliation>
							<affiliation key="aff24">
								<orgName type="department" key="dep1">Cluster of Genetics and Cell Biology</orgName>
								<orgName type="department" key="dep2">Nutrition and Toxicology Research Institute</orgName>
								<orgName type="institution">Maastricht University</orgName>
								<address>
									<settlement>Maastricht</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rajiv</forename><surname>Kumar</surname></persName>
							<affiliation key="aff25">
								<orgName type="department">Division of Molecular Genetic Epidemiology</orgName>
								<orgName type="institution">German Cancer Research Center</orgName>
								<address>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Peter</forename><surname>Rudnai</surname></persName>
							<affiliation key="aff26">
								<orgName type="institution">National Institute of Environmental Health</orgName>
								<address>
									<settlement>Budapest</settlement>
									<country key="HU">Hungary</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Eugene</forename><surname>Gurzau</surname></persName>
							<affiliation key="aff27">
								<orgName type="institution">Environmental Health Center</orgName>
								<address>
									<settlement>Cluj</settlement>
									<country key="RO">Romania</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kvetoslava</forename><surname>Koppova</surname></persName>
							<affiliation key="aff28">
								<orgName type="institution">State Health Institute</orgName>
								<address>
									<settlement>Banska Bystrica</settlement>
									<country key="SK">Slovakia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jose</forename><forename type="middle">Ignacio</forename><surname>Mayordomo</surname></persName>
							<affiliation key="aff29">
								<orgName type="department">Division of Medical Oncology</orgName>
								<orgName type="institution">University Hospital</orgName>
								<address>
									<settlement>Zaragoza</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff31">
								<orgName type="institution">Nanotechnology Institute of Aragon</orgName>
							</affiliation>
							<affiliation key="aff32">
								<orgName type="institution">Health Science Institute</orgName>
								<address>
									<settlement>Zaragoza</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Manuel</forename><surname>Sanchez</surname></persName>
							<affiliation key="aff30">
								<orgName type="department">Division of Urology</orgName>
								<orgName type="institution">University Hospital</orgName>
								<address>
									<settlement>Zaragoza</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Berta</forename><surname>Saez</surname></persName>
							<affiliation key="aff33">
								<orgName type="institution">Health Science Institute</orgName>
								<address>
									<settlement>Zaragoza</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Annika</forename><surname>Lindblom</surname></persName>
							<affiliation key="aff34">
								<orgName type="department">Department of Molecular Medicine and Surgery</orgName>
								<orgName type="institution">Karolinska Institutet</orgName>
								<address>
									<settlement>Stockholm</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Petra</forename><surname>De Verdier</surname></persName>
							<affiliation key="aff35">
								<orgName type="department">Department of Oncology and Pathology</orgName>
								<orgName type="institution">Karolinska Institutet</orgName>
								<address>
									<settlement>Stockholm</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Gunnar</forename><surname>Steineck</surname></persName>
							<affiliation key="aff36">
								<orgName type="department">Department of Oncology</orgName>
								<orgName type="institution">Sahlgrenska University Hospital</orgName>
								<address>
									<settlement>Goteborg</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Gordon</forename><forename type="middle">B</forename><surname>Mills</surname></persName>
							<affiliation key="aff37">
								<orgName type="department">Department of Systems Biology</orgName>
								<orgName type="institution">University of Texas M.D. Anderson Cancer Center</orgName>
								<address>
									<settlement>Houston</settlement>
									<region>Texas</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Alan</forename><surname>Schned</surname></persName>
							<affiliation key="aff38">
								<orgName type="department" key="dep1">Department of Pathology</orgName>
								<orgName type="department" key="dep2">Dartmouth Medical School</orgName>
								<address>
									<settlement>Hanover</settlement>
									<region>New Hampshire</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Simonetta</forename><surname>Guarrera</surname></persName>
							<affiliation key="aff7">
								<orgName type="institution">ISI (Institute for Scientific Interchange) Foundation, Villa Gualino</orgName>
								<address>
									<settlement>Torino</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Silvia</forename><surname>Polidoro</surname></persName>
							<affiliation key="aff7">
								<orgName type="institution">ISI (Institute for Scientific Interchange) Foundation, Villa Gualino</orgName>
								<address>
									<settlement>Torino</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Shen-Chih</forename><surname>Chang</surname></persName>
							<affiliation key="aff13">
								<orgName type="department" key="dep1">Department of Epidemiology</orgName>
								<orgName type="department" key="dep2">School of Public Health</orgName>
								<orgName type="institution">University of California Los Angeles</orgName>
								<address>
									<settlement>Los Angeles</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jie</forename><surname>Lin</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution">University of Texas M.D. Anderson Cancer Center</orgName>
								<address>
									<settlement>Houston</settlement>
									<region>Texas</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">David</forename><forename type="middle">W</forename><surname>Chang</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution">University of Texas M.D. Anderson Cancer Center</orgName>
								<address>
									<settlement>Houston</settlement>
									<region>Texas</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Katherine</forename><forename type="middle">S</forename><surname>Hale</surname></persName>
							<affiliation key="aff37">
								<orgName type="department">Department of Systems Biology</orgName>
								<orgName type="institution">University of Texas M.D. Anderson Cancer Center</orgName>
								<address>
									<settlement>Houston</settlement>
									<region>Texas</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Tadeusz</forename><surname>Majewski</surname></persName>
							<affiliation key="aff12">
								<orgName type="department">Department of Pathology</orgName>
								<orgName type="institution">University of Texas</orgName>
								<address>
									<addrLine>M.D. Anderson Cancer Center</addrLine>
									<settlement>Houston</settlement>
									<region>Texas</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">H</forename><forename type="middle">Barton</forename><surname>Grossman</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Steinunn</forename><surname>Thorlacius</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">deCODE Genetics</orgName>
								<address>
									<settlement>Reykjavik</settlement>
									<country key="IS">Iceland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Unnur</forename><surname>Thorsteinsdottir</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">deCODE Genetics</orgName>
								<address>
									<settlement>Reykjavik</settlement>
									<country key="IS">Iceland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Katja</forename><forename type="middle">K H</forename><surname>Aben</surname></persName>
							<affiliation key="aff4">
								<orgName type="institution">Comprehensive Cancer Center East</orgName>
								<address>
									<settlement>Nijmegen</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">J</forename><forename type="middle">Alfred</forename><surname>Witjes</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Urology</orgName>
								<orgName type="institution">Radboud University Nijmegen Medical Centre</orgName>
								<address>
									<settlement>Nijmegen</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kari</forename><surname>Stefansson</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">deCODE Genetics</orgName>
								<address>
									<settlement>Reykjavik</settlement>
									<country key="IS">Iceland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christopher</forename><forename type="middle">I</forename><surname>Amos</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution">University of Texas M.D. Anderson Cancer Center</orgName>
								<address>
									<settlement>Houston</settlement>
									<region>Texas</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Margaret</forename><forename type="middle">R</forename><surname>Karagas</surname></persName>
							<affiliation key="aff8">
								<orgName type="department" key="dep1">Epidemiology and Genetics Research Program</orgName>
								<orgName type="department" key="dep2">Division of Cancer Control and Population Sciences</orgName>
								<orgName type="institution">National Cancer Institute</orgName>
								<address>
									<settlement>Bethesda</settlement>
									<region>Maryland</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jian</forename><surname>Gu</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution">University of Texas M.D. Anderson Cancer Center</orgName>
								<address>
									<settlement>Houston</settlement>
									<region>Texas</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff15">
								<orgName type="department">Institute of Molecular Medicine</orgName>
								<orgName type="institution">St. James&apos;s University Hospital</orgName>
								<address>
									<settlement>Leeds</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Nature Genetics</title>
						<title level="j" type="abbrev">Nat Genet</title>
						<idno type="ISSN">1061-4036</idno>
						<idno type="eISSN">1546-1718</idno>
						<imprint>
							<publisher>Springer Science and Business Media LLC</publisher>
							<biblScope unit="volume">41</biblScope>
							<biblScope unit="issue">9</biblScope>
							<biblScope unit="page" from="991" to="995"/>
							<date type="published" when="2012-03-27">2012 March 27.</date>
						</imprint>
					</monogr>
					<idno type="MD5">E6276A91A960EF871CBD750152173E96</idno>
					<idno type="DOI">10.1038/ng.421</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.0" ident="GROBID" when="2025-04-21T20:07+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Supplementary information is available on the Nature Genetics website.</s><s>AUTHOR CONTRIBUTIONS Texas: X.W. conceived this study and established the M.D. Anderson bladder cancer study, supervised laboratory and statistical analyses and wrote the initial draft of the manuscript.</s><s>Y.Y. supervised and performed statistical analyses.</s><s>C.P.D., B.C. and H.B.G. were involved in patient recruitment.</s><s>J.L. was involved in epidemiologic data collection and database management.</s><s>D.W.C performed in vitro assays.</s><s>T.M., G.B.M. and K.S.H. were involved in the validation genotyping.</s><s>C.I.A. provided guidance in statistical analyses, assisted in the initial development of the research and contributed in manuscript preparation.</s><s>J.G. was involved in the development of the research and study design, oversaw genotyping and in vitro assays and wrote the initial draft of the manuscript.</s><s>Other sites: L.A.K. and T.R. organized and supervised the replication efforts in European populations.</s><s>P.S. performed primary statistical analysis of European populations.</s><s>G.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Bladder cancer is the fourth most common cancer in men in the United States, with an estimated 68,810 new cases and 14,410 deaths from this disease in 2008 (ref.</s><s>1).</s><s>The main environmental risk factors for bladder cancer are cigarette smoking and occupational exposure.</s><s>There is also compelling evidence for a genetic component to the etiology of bladder cancer.</s><s>In a large twin study, it was estimated that inherited genetic susceptibility contributes to 31% of bladder cancer risk <ref type="bibr" target="#b1">2</ref> .</s><s>Case reports have described familial clustering of bladder cancer <ref type="bibr" target="#b2">3</ref> .</s><s>Epidemiological studies showed that the risk of the disease increased by 50%-100% in first-degree relatives of individuals with bladder cancer <ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref> .</s><s>However, genetic loci that account for most familial risk of bladder cancer remain elusive.</s><s>A recent segregation analysis suggested a 'no major gene' model <ref type="bibr" target="#b7">8</ref> .</s><s>Candidate gene association studies have shown that NAT2 slow acetylator and GSTM1 null genotypes are associated with increased bladder cancer risks <ref type="bibr" target="#b8">9</ref> .</s><s>A recent genome-wide association study (GWAS) identified two bladder cancer susceptibility loci <ref type="bibr" target="#b9">10</ref> .</s><s>To identify additional bladder cancer susceptibility loci, we conducted a GWAS using the Illumina HumanHap610 Beadchip.</s></p><p><s>We performed the primary screen using an ongoing case-control study in Texas.</s><s>We restricted study participants to self-reported Caucasians to minimize confounding by ethnicity.</s><s>After applying strict quality control criteria (see Online Methods for details) to remove problematic samples and SNPs, we analyzed 556,429 SNPs in 969 cases and 957 controls.</s><s>A quantile-quantile plot of observed versus expected χ 2 test statistics showed no evidence for inflation of chi-squared tests (inflation factor λ = 1.002;</s><s>Supplementary Fig. <ref type="figure" target="#fig_0">1</ref>).</s><s>None of the SNPs reached genome-wide significance at this stage (Supplementary Fig. <ref type="figure" target="#fig_1">2</ref>).</s><s>After we removed highly linked SNPs, three SNPs had a P-value &lt; 10 -5 and 50 SNPs showed a P-value &lt; 10 -4 (Supplementary Table <ref type="table" target="#tab_0">1</ref>).</s><s>We adjusted the results for population substructure using Cochran-Mantel-Haenszel tests, eigenvectors and permutation tests, and the P-values were consistent (Supplementary Table <ref type="table" target="#tab_0">1</ref>).</s></p><p><s>We used three more US sets to perform a fast-track replication of the top 50 SNPs (P &lt; 10 -4 ) and the top 10 additional SNPs in 8q24 (P &lt; 5 × 10 -3 ), a region associated with genetic susceptibility to several cancers <ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref> .</s><s>One SNP (rs2294008) was consistent across the US discovery and the replication sets (P = 7.34 × 10 -4 and 3.53 × 10 -5 , respectively; Table <ref type="table" target="#tab_0">1</ref>).</s><s>The P-value was 1.07 × 10 -7 in the combined US populations (Supplementary Table <ref type="table" target="#tab_2">2</ref>).</s><s>We next used nine European populations to replicate this SNP.</s><s>The overall Pvalue for the combined European populations was 9.83 × 10 -5 .</s><s>Combining all US and European subjects (6,667 cases, 39,590 controls), the P-value was 2.14 × 10 -10 (Table <ref type="table" target="#tab_0">1</ref>).</s><s>The allelic odds ratio (OR) was 1.15 (95% confidence interval (CI), 1.10-1.20).</s><s>There was no significant heterogeneity among the ORs of all the populations (P for heterogeneity = 0.423).</s><s>We also performed a multivariable logistic regression analysis, adjusting for age, gender and smoking status (5,038 cases and 9,363 controls, excluding three European populations with missing individual age or smoking data for controls; Table <ref type="table" target="#tab_2">2</ref>).</s><s>The OR for individuals carrying one copy of the variant allele (T) was 1.30 (95% CI, 1.18-1.42)</s><s>and for those carrying two copies was 1.40 (95% CI, 1.25-1.56).</s><s>We tested the equality of the ORs for heterozygous and homozygous carriers of the variant allele and observed a nonsignificant P-value of 0.14, suggesting a dominant model.</s><s>The OR for individuals carrying at least one variant allele was 1.33 (95% CI, 1.22-1.45).</s><s>We also performed stratified analyses for age, gender and smoking status and observed similar associations across different strata (Table <ref type="table" target="#tab_2">2</ref>).</s><s>The association was also similar in superficial and invasive bladder cancer (for US populations only; data not shown).</s><s>The risk allele (T) frequency is 46%, and individuals carrying the homozygous risk genotype (TT) account for about 22% of the control population.</s><s>rs2294008 is a missense SNP located in exon 1 of the PSCA gene.</s><s>Linkage disequilibrium (LD) analysis of all HapMap SNPs in the vicinity of rs2294008 showed that it maps to an 11-kb LD block on chromosome 8q24 (Fig. <ref type="figure" target="#fig_0">1</ref>).</s><s>We imputed genotypes within 1 Mb of rs2294008 for SNPs in the HapMap database but not on the HumanHap610 chip.</s><s>rs2294008 was among the top SNPs showing the strongest association (Fig. <ref type="figure" target="#fig_0">1a</ref>).</s><s>To identify unknown variants, we resequenced the genomic region of PSCA in 106 individuals of European ancestry.</s><s>We found 27 SNPs, 23 of which had a minor allele frequency (MAF) &gt; 5% (Supplementary Table <ref type="table" target="#tab_3">3</ref>).</s><s>Several of these SNPs are listed in the dbSNP database, but this study is the first to validate them (SNPs no. 4, no. 5, no. 9 and no.</s><s>16).</s><s>We also validated an insertion/deletion polymorphism (no.</s><s>7) and identified two new low-frequency SNPs (no. 1 and no.</s><s>2).</s><s>All of the high frequency SNPs are in strong LD (D′ &gt; 0.9) with rs2294008.</s><s>We genotyped seven of these SNPs in our discovery set and observed nearly identical ORs compared to rs2294008 (Supplementary Table <ref type="table">4</ref>).</s></p><p><s>A recent study <ref type="bibr" target="#b14">15</ref> found that the T allele of rs2294008 resulted in a significant reduction in transcriptional activity of the PSCA promoter in gastric cell lines.</s><s>We obtained four constructs representing the top four 5′ upstream haplotypes (including promoter and exon 1 region) in our populations (Fig. <ref type="figure" target="#fig_1">2</ref>).</s><s>Except for the wild-type haplotype, the other three haplotypes all contained the variant T allele at rs2294008.</s><s>We found that in three different bladder cancer cell lines (UC1, UC3 and UC13) the T allele-containing haplotypes showed significantly lower promoter activity (P &lt; 0.001 for all comparisons between wild-type and the other three constructs; Fig. <ref type="figure" target="#fig_1">2b</ref>).</s><s>Furthermore, substitution of a single nucleotide in the wild-type haplotype (rs2294008 C to T) significantly reduced promoter activity, whereas a single substitution of rs2294008 T to C in UP-H1 increased promoter activity (Fig. <ref type="figure" target="#fig_1">2c</ref>).</s><s>These results are in complete concordance with data in gastric cancer <ref type="bibr" target="#b14">15</ref> , providing compelling evidence that rs2294008 is a functional variant in vitro.</s><s>We then used real-time PCR to detect PSCA mRNA expression in nine bladder cancer cell lines.</s><s>We found that UC9 (TT genotype) had the highest expression, whereas three CT-genotype cell lines (UC1, UC5 and UC7) showed intermediate expression, and three CC genotype cell lines (UC3, UC13 and UC17) and two TT cell lines (UC12 and UC18) showed very low expression (data not shown).</s><s>This lack of genotype-expression correlation in cancer cell lines is likely due to somatic changes because PSCA is upregulated in most bladder tumors <ref type="bibr" target="#b15">16</ref> .</s><s>By contrast, expression of PSCA in most normal tissues is very low, except for prostate, esophagus and stomach <ref type="bibr" target="#b16">17,</ref><ref type="bibr" target="#b17">18</ref> .</s><s>We did not have normal bladder tissues and thus could not measure PSCA expression in them.</s><s>We used 135 lymphoblastoid cell lines with different genotypes of rs2294008 (TT, CT and CC) and attempted to determine PSCA mRNA expression, but PSCA mRNA was not detectable (data not shown).</s><s>Finding sufficient numbers of normal tissue samples, particularly of tissues abundantly expressing PSCA (prostate, esophagus and stomach), is warranted in order to compare endogenous PSCA expression for the different rs2294008 genotypes and determine whether the T allele reduces PSCA gene expression in vivo.</s></p><p><s>Previous GWASs have identified several independent susceptibility alleles at 8q24 for prostate, breast and colorectal cancers <ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref> .</s><s>None of these SNPs showed significant associations with bladder cancer risk in our discovery set (Table <ref type="table" target="#tab_3">3</ref>).</s><s>The power calculation showed that we had adequate power (&gt;80%) to detect an OR of 1.33 for an additive model and 1.37 for a dominant model when the MAF was greater than 0.10 in our discovery set.</s><s>These 8q24 SNPs have also been examined in the nine European studies previously <ref type="bibr" target="#b9">10</ref> , and the results were consistent with ours.</s><s>The 8q24 SNP (rs9642880) identified from the previous bladder cancer GWAS <ref type="bibr" target="#b9">10</ref> was validated in our US populations (OR = 1.14; 95% CI, 1.06-1.22;</s><s>P = 2.1 × 10 -4 ; Table <ref type="table" target="#tab_3">3</ref>).</s><s>When we performed a meta-analysis of all the US and European populations, the OR was 1.19 (95% CI, 1.14-1.24;</s><s>P = 1.35 × 10 -14 ; Supplementary Fig. <ref type="figure">3a</ref>).</s><s>We also validated a second SNP (rs710521) at 3q28 (OR = 1.16, 95% CI, 1.10-1.22;</s><s>P = 1.09 × 10 -8 ; Supplementary Fig. <ref type="figure">3b</ref>).</s></p><p><s>PSCA was initially identified as a prostate-specific cell-surface marker <ref type="bibr" target="#b16">17</ref> .</s><s>PSCA is overexpressed in prostate cancer, and the level of expression increases with tumor grade and stage <ref type="bibr" target="#b16">17,</ref><ref type="bibr" target="#b18">19</ref> .</s><s>It may be involved in cell proliferation, and migration as monoclonal antibodies to PSCA could inhibit tumor growth and metastasis formation in animal models <ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b20">21</ref> .</s><s>PSCA is expressed at low levels in the transitional epithelium of normal bladder but is overexpressed in the majority of bladder cancers <ref type="bibr" target="#b15">16</ref> .</s><s>Immunocytochemical analysis of PSCA in voided urine was shown to be a complementary marker for cytological diagnosis of bladder cancer <ref type="bibr" target="#b21">22</ref> .</s><s>The expression level of PSCA was an independent predictor of recurrence in superficial bladder cancer <ref type="bibr" target="#b22">23</ref> .</s><s>These observations provide biological plausibility for the association between PSCA and bladder cancer risk.</s><s>rs2294008 is a missense variation that alters the start codon of PSCA.</s><s>The first report on PSCA protein <ref type="bibr" target="#b16">17</ref> was based on the cDNA sequence carrying the T allele (the longer, 123amino-acid protein).</s><s>In the cDNA sequence carrying the C allele, the translation is predicted to start from the next ATG codon, resulting in a nine-amino-acid truncation.</s><s>In vitro translation showed that cDNA sequences containing these two alleles produced proteins of almost the same size, compatible with a difference of only nine amino acids <ref type="bibr" target="#b14">15</ref> .</s><s>PSCA is a member of the Thy-1/Ly-6 family of glycosylphosphatidylinositol (GPI)-anchored cell surface proteins.</s><s>All GPI-anchored proteins undergo complex cellular processing before becoming mature protein <ref type="bibr" target="#b23">24</ref> .</s><s>The 123-amino-acid primary PSCA translation product, like other GPI-anchored proteins, has two signal sequences: an N-terminal signal sequence (20 amino acids) for endoplasmic reticulum targeting and a C-terminal sequence that directs the GPI-anchoring <ref type="bibr" target="#b14">15</ref> .</s><s>Both these signal sequences are removed in the endoplasmic reticulum, and the GPI-anchored form is then carried through a secretory pathway to the cell surface.</s><s>Therefore, the mature proteins are the same for the two alleles of rs2294008.</s><s>However, because rs2294008 changes the length of the N-terminal signal peptide, it may change protein folding, intracellular modifications and/or trafficking of PSCA proteins.</s><s>An in vitro assay using EYFP (enhanced yellow fluorescent protein)-fused PSCA expression vectors transfected into HSC60 cells found no detectable difference in the amount or distribution of the EYFP-fused short and long forms of PSCA protein <ref type="bibr" target="#b14">15</ref> .</s><s>In vivo measurements of PSCA protein have been challenging owing to the low expression of PSCA in most normal tissues and the uncertainty of the sensitivity and specificity of the available PSCA antibody.</s><s>Furthermore, if the truncated N-terminal signal peptide affects protein folding and/or intracellular modifications, then an antibody could recognize mature PSCA protein processed from the long and short signal sequences differently even though the mature protein sequence is the same.</s><s>Future efforts are needed to determine the protein expression and physiological function of PSCA and the functional consequence of rs2294008 in vivo.</s></p><p><s>rs2294008 was recently identified as a susceptibility allele for diffuse-type gastric cancer in Japan <ref type="bibr" target="#b14">15</ref> .</s><s>Notably, the T allele has higher frequency in individuals of European ancestry (MAF = 0.46) and Koreans (MAF = 0.46) than in Chinese (MAF = 0.26) and Africans (MAF = 0.25), based on HapMap data; however, it is a major allele in Japanese (frequency = 0.62).</s><s>The population genetic history of this SNP and why only Japanese possess a different minor allele remain to be explained.</s><s>Whether rs2294008 is associated with gastric cancer or any other cancers in individuals of European descent warrants further investigation.</s></p><p><s>The T allele reduced the transcriptional activity of the PSCA promoter in vitro.</s><s>It seems paradoxical that the T risk allele reduces transcription, whereas PSCA has been shown to be overexpressed in bladder tumors.</s><s>Because the physiological function of PSCA and the functional impact of different N-terminal signal lengths on protein function are still unknown the functional consequence of the risk T allele in vivo is unclear, but it would be the cumulative result of transcriptional, translational and post-translational effects.</s><s>All the previously identified cancer susceptibility variants in 8q24 in individuals of European descent are located near the MYC gene, and the causal variants and biologic mechanisms remain elusive.</s><s>rs2294008 (position 143758933) is 15 Mb distal from the previous bladder cancer susceptibility locus (rs9642880, position 128787250) on 8q24, and these two SNPs are not in LD (D′ = 0.01, r 2 = 0.00), suggesting that rs2294008 is an independent bladder cancer susceptibility locus on 8q24.</s><s>Future functional studies are warranted to delineate the physiological role of PSCA and the biological mechanisms underlying the association of rs2294008 in PSCA with bladder carcinogenesis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>METHODS</head><p><s>Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/.</s><s>In vitro reporter assay of the four most frequent haplotypes of the PSCA 5′ upstream region (nucleotides -3236 to +28).</s><s>(a) The four SNPs that comprise these haplotypes are rs2976387, rs6471587, rs13262164 and rs2294008.</s><s>The frequencies of top four haplotypes in our population were wild-type (G-C-C-C), 58%; UP-H1 (A-C-T-T), 25%; UP-H2 (A-C-C-T), 16%; and UP-H3 (G-G-C-T), 1%, respectively.</s><s>(b) Three bladder cell lines were transfected with a luciferase (Luc) reporter gene driven by PSCA upstream sequences containing these four haplotypes.</s><s>In all three cell lines, the wild-type sequence (containing C at rs2294008) showed significantly higher promoter activity than the other three (all containing T at rs2294008) (P &lt; 0.001).</s><s>(c) Substitution of a single nucleotide (rs2294008 C to T) in the wild-type haplotype significantly reduced promoter activity, whereas a single substitution (rs2294008 T to C) in UP-H1 increased promoter activity to a level comparable to that in wild-type in UC1 cells.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>The 8q24 locus encompassing rs2294008.</s><s>(a) Results of SNP association from the genomewide screen.</s><s>Observed results from genotyped SNPs are in red and imputed results are in black.</s><s>All known genes in this region are also shown.</s><s>(b) LD structure of this region.</s><s>Red arrow, position of rs2294008.</s><s>Represented in each location is the square of the correlation coefficient (r 2 ) derived from phase 2 genotypes in Haploview software (version 4.1), with darker shading indicating greater extent of LD between two SNPs.</s><s>Triangles represent LD blocks identified by Haploview software.</s></p></div></figDesc><graphic coords="8,84.06,61.00,503.87,473.04" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2.</s></p></div></figDesc><graphic coords="9,137.28,61.00,397.44,504.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p><s>Summary results of rs2294008 in discovery and replication populations</s></p></div></figDesc><table><row><cell>Study</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>group Cases n = 6,667 Controls n = 39,590 MAF Allelic OR (95% CI) P value P for heterogeneity</head><label></label><figDesc></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>0.456</cell><cell>0.498</cell><cell>0.423</cell></row><row><cell></cell><cell>7.34 × 10 -4</cell><cell></cell><cell>2.87 × 10 -3</cell><cell>0.018</cell><cell>0.04</cell><cell></cell><cell>0.278</cell><cell>0.1</cell><cell>0.123</cell><cell>0.506</cell><cell>0.876</cell><cell>5.25 × 10 -3</cell><cell>0.355</cell><cell>0.9</cell><cell>7.37 × 10 -3</cell><cell></cell><cell>7.34 × 10 -4</cell><cell>3.53 × 10 -5</cell><cell>9.83 × 10 -5</cell><cell>2.14 × 10 -10</cell></row><row><cell></cell><cell>1.24 (1.10-1.41)</cell><cell></cell><cell>1.23 (1.07-1.41)</cell><cell>1.15 (1.02-1.29)</cell><cell>1.40 (1.02-1.94)</cell><cell></cell><cell>1.07 (0.95-1.20)</cell><cell>1.09 (0.98-1.20)</cell><cell>1.14 (0.97-1.34)</cell><cell>1.08 (0.86-1.34)</cell><cell>1.02 (0.77-1.37)</cell><cell>1.29 (1.08-1.54)</cell><cell>1.12 (0.88-1.44)</cell><cell>1.01 (0.81-1.27)</cell><cell>1.36 (1.09-1.71)</cell><cell></cell><cell>1.24 (1.10-1.41)</cell><cell>1.19 (1.10-1.30)</cell><cell>1.12 (1.06-1.18)</cell><cell>1.15 (1.10-1.20)</cell></row><row><cell>Cases Controls</cell><cell>957 0.501 0.446</cell><cell></cell><cell>912 0.499 0.448</cell><cell>2,807 0.485 0.450</cell><cell>152 0.527 0.443</cell><cell></cell><cell>28,757 0.485 0.469</cell><cell>1,831 0.471 0.449</cell><cell>514 0.458 0.426</cell><cell>310 0.458 0.439</cell><cell>190 0.448 0.442</cell><cell>909 0.513 0.450</cell><cell>380 0.500 0.471</cell><cell>1,362 0.439 0.435</cell><cell>509 0.521 0.444</cell><cell></cell><cell>957 0.501 0.446</cell><cell>3,871 0.495 0.449</cell><cell>34,762 0.475 0.465</cell><cell>39,590 0.484 0.463</cell></row><row><cell></cell><cell>969</cell><cell></cell><cell>800</cell><cell>764</cell><cell>149</cell><cell></cell><cell>551</cell><cell>1,276</cell><cell>706</cell><cell>357</cell><cell>182</cell><cell>335</cell><cell>192</cell><cell>172</cell><cell>214</cell><cell></cell><cell>969</cell><cell>1,713</cell><cell>3,985</cell><cell>6,667</cell></row><row><cell></cell><cell>Discovery (Texas)</cell><cell>US validation</cell><cell>New Hampshire</cell><cell>Texas</cell><cell>MSKCC</cell><cell>European validation</cell><cell>Iceland</cell><cell>Netherlands</cell><cell>UK</cell><cell>Italy-Torino</cell><cell>Italy-Brescia</cell><cell>Sweden</cell><cell>Belgium</cell><cell>Spain</cell><cell>Eastern Europe (Hungary, Romania, Slovakia)</cell><cell>Summary</cell><cell>Discovery</cell><cell>US validation</cell><cell>European validation</cell><cell>All combined</cell></row></table><note><p><s>Nat Genet.</s><s>Author manuscript; available in PMC 2012 March 27.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2</head><label>2</label><figDesc><div><p><s>Multivariate logistic regression analysis of rs2294008Excludes Iceland, UK and Sweden populations owing to lack of individual epidemiologic data in controls.</s><s>b Age cutoff is the median age in controls.</s><s>c Adjusted for age, gender, smoking status and study site.</s><s>d Adjusted for age, smoking status and study site.</s></p></div></figDesc><table><row><cell></cell><cell>P for heterogeneity</cell><cell></cell><cell>0.58</cell><cell></cell><cell>0.22</cell><cell></cell><cell>0.57</cell><cell></cell><cell>0.30</cell><cell></cell><cell>0.53</cell><cell></cell><cell>0.87</cell><cell></cell><cell>0.52</cell></row><row><cell></cell><cell>P-value</cell><cell></cell><cell>1.30 × 10 -10</cell><cell></cell><cell>2.05 × 10 -8</cell><cell></cell><cell>2.47 × 10 -3</cell><cell></cell><cell>5.50 × 10 -5</cell><cell></cell><cell>1.20 × 10 -6</cell><cell></cell><cell>4.20 × 10 -4</cell><cell></cell><cell>1.41 × 10 -7</cell></row><row><cell>Genotype</cell><cell>CT TT Dominant</cell><cell>2,613 / 4,668 1,137 / 1,853</cell><cell>1.30 (1.18-1.42) 1.40 (1.25-1.56) 1.33 (1.22-1.45)</cell><cell>2,147 / 2,500 932 / 1,028</cell><cell>1.30 (1.17-1.44) 1.38 (1.21-1.56) 1.32 (1.20-1.45)</cell><cell>464 / 1,827 202 / 694</cell><cell>1.29 (1.06-1.58) 1.48 (1.16-1.88) 1.34 (1.11-1.62)</cell><cell>511 / 1,431 239 / 574</cell><cell>1.41 (1.17-1.70) 1.54 (1.23-1.93) 1.45 (1.21-1.73)</cell><cell>1,938 / 2,825 834 / 1,116</cell><cell>1.26 (1.13-1.39) 1.34 (1.18-1.52) 1.28 (1.16-1.41)</cell><cell>1,054 / 2,318 431 / 890</cell><cell>1.24 (1.08-1.43) 1.35 (1.14-1.61) 1.27 (1.11-1.45)</cell><cell>1,559 / 2,350 706 / 963</cell><cell>1.33 (1.17-1.50) 1.44 (1.24-1.66) 1.36 (1.21-1.52)</cell></row><row><cell></cell><cell>All CC</cell><cell>5,038 / 9,363 1,288 / 2,842</cell><cell>1</cell><cell>4,159 / 5,104 1,080 / 1,576</cell><cell>1</cell><cell>871 / 3,558 205 / 1,037</cell><cell>1</cell><cell>983 / 2,871 233 / 866</cell><cell>1</cell><cell>3,727 / 5,660 955 / 1719</cell><cell>1</cell><cell>1,996 / 4,561 511 / 1,353</cell><cell>1</cell><cell>3,042 / 4,802 777 / 1,489</cell><cell>1</cell></row><row><cell></cell><cell></cell><cell>Case/Control</cell><cell>OR c (95% CI)</cell><cell>Case/Control</cell><cell>OR d (95% CI)</cell><cell>Case/Control</cell><cell>OR d (95% CI)</cell><cell>Case/Control</cell><cell>OR e (95% CI)</cell><cell>Case/Control</cell><cell>OR e (95% CI)</cell><cell>Case/Control</cell><cell>OR c (95% CI)</cell><cell>Case/Control</cell><cell>OR c (95% CI)</cell></row><row><cell></cell><cell></cell><cell>All a</cell><cell></cell><cell>Male</cell><cell></cell><cell>Female</cell><cell></cell><cell>Never smoker</cell><cell></cell><cell>Ever smoker</cell><cell></cell><cell>Age ≤ 62 b</cell><cell></cell><cell>Age &gt; 62 b</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>a</cell></row></table><note><p><s>eAdjusted for age, gender and study site.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 3</head><label>3</label><figDesc><div><p><s>Previously reported cancer susceptibility alleles on 8q24 and bladder cancer risk a Results for rs9642880 were from all US populations; results of other SNPs were from discovery phase population.</s></p></div></figDesc><table><row><cell></cell><cell>Reported</cell><cell>cancer</cell><cell>association</cell><cell>Prostate</cell><cell></cell><cell>Breast</cell><cell></cell><cell>Prostate,</cell><cell>colorectal</cell><cell>Prostate</cell><cell></cell><cell>Bladder</cell></row><row><cell>LD with</cell><cell>rs2294008</cell><cell></cell><cell>D′</cell><cell>0.02</cell><cell></cell><cell>0.03</cell><cell></cell><cell>0.01</cell><cell></cell><cell>0.07</cell><cell></cell><cell>0.01</cell></row><row><cell></cell><cell></cell><cell></cell><cell>P-value</cell><cell>0.688</cell><cell></cell><cell>0.868</cell><cell></cell><cell>0.815</cell><cell></cell><cell>0.090</cell><cell></cell><cell>2.1 × 10 -4</cell></row><row><cell></cell><cell></cell><cell>OR</cell><cell>(95% CI)</cell><cell>1.08</cell><cell>(0.75-1.56)</cell><cell>1.01</cell><cell>(0.89-1.15)</cell><cell>1.02</cell><cell>(0.89-1.15)</cell><cell>1.21</cell><cell>(0.97-1.50)</cell><cell>1.14</cell><cell>(1.06-1.22)</cell></row><row><cell></cell><cell>Allele MAF</cell><cell></cell><cell>SNP Position Major Minor Case Control</cell><cell cols="2">0.031 0.029 rs10505483 b 128194377 G A</cell><cell>0.414 0.412 rs13281615 128424800 A G</cell><cell></cell><cell>0.491 0.487 rs6983267 128482487 C A</cell><cell></cell><cell>0.102 0.086 rs1447295 128554220 C A</cell><cell></cell><cell>0.488 0.457 rs9642880 128787250 G T</cell><cell>a</cell><cell>b rs10505483 is in complete LD with rs16901979.</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p><s>Nat Genet.</s><s>Author manuscript; available in PMC 2012 March 27.</s></p></note>
		</body>
		<back>

			<div type="acknowledgement">
<div><head>Acknowledgments</head><p>The study was partially supported by <rs type="funder">NIH</rs> grants <rs type="grantNumber">U01 CA 127615</rs> (X.W.), <rs type="grantNumber">R01 CA 74880</rs> (X.W.), <rs type="grantNumber">P50 CA 91846</rs> (X.W., C.P.D.), <rs type="grantNumber">R01 CA 133996 (C.I.A</rs>), <rs type="grantNumber">P42 ES07373</rs> (M.R.K.) and <rs type="grantNumber">R01 CA 57494</rs> (M.R.K.), <rs type="grantNumber">R01 CA 131335</rs> (J.G.) and the <rs type="institution">Kleberg Center for Molecular Markers at MDACC</rs>.We thank the genotyping personnel, study coordinators and interviewers for performing experiments and recruiting participants.We are especially thankful for all the study participants who made the population-based research possible.</p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_94jHPGZ">
					<idno type="grant-number">U01 CA 127615</idno>
				</org>
				<org type="funding" xml:id="_dt2pg83">
					<idno type="grant-number">R01 CA 74880</idno>
				</org>
				<org type="funding" xml:id="_8pffpmV">
					<idno type="grant-number">P50 CA 91846</idno>
				</org>
				<org type="funding" xml:id="_wMkURF3">
					<idno type="grant-number">R01 CA 133996 (C.I.A</idno>
				</org>
				<org type="funding" xml:id="_agB9t7j">
					<idno type="grant-number">P42 ES07373</idno>
				</org>
				<org type="funding" xml:id="_69hcWwj">
					<idno type="grant-number">R01 CA 57494</idno>
				</org>
				<org type="funding" xml:id="_3Tr8vkb">
					<idno type="grant-number">R01 CA 131335</idno>
				</org>
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supplementary Material</head><p><s>Refer to Web version on PubMed Central for supplementary material.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Cancer statistics</title>
		<author>
			<persName><forename type="first">A</forename><surname>Jemal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">CA Cancer J. Clin</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="71" to="96" />
			<date type="published" when="2008">2008. 2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 18287387</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland</title>
		<author>
			<persName><forename type="first">P</forename><surname>Lichtenstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N. Engl. J. Med</title>
		<imprint>
			<biblScope unit="volume">343</biblScope>
			<biblScope unit="page">10891514</biblScope>
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Familial bladder cancer</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Kiemeney</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Textbook of Bladder Cancer</title>
		<editor>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Lerner</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">M</forename><surname>Schoenberg</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">C</forename><surname>Sternberg</surname></persName>
		</editor>
		<meeting><address><addrLine>London</addrLine></address></meeting>
		<imprint>
			<publisher>T&amp;F-Informa</publisher>
			<date type="published" when="2006">2006</date>
			<biblScope unit="page" from="19" to="25" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Familial and environmental interactions in bladder cancer risk</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Kantor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hartge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Hoover</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Fraumeni</surname><genName>Jr</genName></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int. J. Cancer</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="703" to="706" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
	<note>PubMed: 4008097</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Familial transitional cell carcinoma</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Kiemeney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schoenberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Urol</title>
		<imprint>
			<biblScope unit="volume">156</biblScope>
			<biblScope unit="page" from="867" to="872" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note>PubMed: 8709350</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families</title>
		<author>
			<persName><forename type="first">C</forename><surname>Dong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hemminki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int. J. Cancer</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="144" to="150" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note>PubMed: 11279618</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Familial aggregation of urothelial cell carcinoma</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Aben</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int. J. Cancer</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="274" to="278" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note>PubMed: 11857419</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Segregation analysis of urothelial cell carcinoma</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Aben</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur. J. Cancer</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="1428" to="1433" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>PubMed: 16737809</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses</title>
		<author>
			<persName><forename type="first">M</forename><surname>Garcia-Closas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">366</biblScope>
			<biblScope unit="page" from="649" to="659" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>PubMed: 16112301</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Sequence variant on 8q24 confers susceptibility to urinary bladder cancer</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Kiemeney</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="1307" to="1312" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 18794855</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Genome-wide association study identifies novel breast cancer susceptibility loci</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Easton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">447</biblScope>
			<biblScope unit="page" from="1087" to="1093" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>PubMed: 17529967</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24</title>
		<author>
			<persName><forename type="first">J</forename><surname>Gudmundsson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page">17401366</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21</title>
		<author>
			<persName><forename type="first">I</forename><surname>Tomlinson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="984" to="988" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>PubMed: 17618284</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Genome-wide association study of prostate cancer identifies a second risk locus at 8q24</title>
		<author>
			<persName><forename type="first">M</forename><surname>Yeager</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page">17401363</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Study Group of Millennium Genome Project for Cancer. Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer</title>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="730" to="740" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 18488030</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Prostate stem cell antigen is overexpressed in human transitional cell carcinoma</title>
		<author>
			<persName><forename type="first">N</forename><surname>Amara</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="4660" to="4665" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note>PubMed: 11406532</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Reiter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="1735" to="1740" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note>PubMed: 9465086</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Reduced expression of PSCA, a member of the LY-6 family of cell surface antigen, in bladder, esophagus, and stomach tumors</title>
		<author>
			<persName><forename type="first">G</forename><surname>Bahrenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Brauers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H-G</forename><surname>Joost</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Jakse</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Biophys. Res. Commun</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="page" from="783" to="788" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note>PubMed: 10973799</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Prostate stem cell antigen (PSCA) expression increases with high Gleason score, advanced stage and bone metastasis in prostate cancer</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Gu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="1288" to="1296" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note>PubMed: 10713670</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Saffran</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="2658" to="2663" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note>PubMed: 11226295</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Anti-prostate stem cell antigen monoclonal antibody 1G8 induces cell death in vitro and inhibits tumor growth in vivo via a Fc-independent mechanism</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Gu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yamashiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kono</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Reiter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="9495" to="9500" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>PubMed: 16230414</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Immunocytochemical analysis of prostate stem cell antigen as adjunct marker for detection of urothelial transitional cell carcinoma in voided urine specimens</title>
		<author>
			<persName><forename type="first">L</forename><surname>Cheng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Urol</title>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="page" from="2094" to="2100" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note>PubMed: 12771726</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder</title>
		<author>
			<persName><forename type="first">E</forename><surname>Elsamman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BJU Int</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="1202" to="1207" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>PubMed: 16686711</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Thematic review series: lipid posttranslational modifications. GPI anchoring of protein in yeast and mammalian cells, or: how we learned to stop worrying and love glycophospholipids</title>
		<author>
			<persName><forename type="first">P</forename><surname>Orlean</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Menon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Lipid Res</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="993" to="1011" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>PubMed: 17361015</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
